TLDR The document concludes that Polycystic Ovary Syndrome is a commonly underdiagnosed hormonal disorder in women, diagnosed by specific criteria.
The document reviewed Polycystic Ovary Syndrome (PCOS), a hormonal disorder affecting 5% to 15% of women of reproductive age, which is often underdiagnosed. It highlighted diagnostic criteria recommended by the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine, which include the presence of at least two of the following: oligoovulation or anovulation, high levels of androgens, or polycystic ovaries, after ruling out other conditions. The document summarized the improved recognition of PCOS but did not provide specific study data or participant numbers.
14 citations,
February 2016 in “Journal of Obstetrics and Gynaecology Research” Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.
1 citations,
August 2013 in “Springer eBooks” Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.
3 citations,
January 2012 in “Hanyang Medical Reviews” The document concludes that more research is needed to create suitable diagnostic criteria and understand PCOS in Korean women, and genetics may allow for personalized treatment.
85 citations,
June 2006 in “Best Practice & Research Clinical Endocrinology & Metabolism” The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.
1 citations,
April 1993 in “Problemy e̊ndokrinologii” Spironolactone effectively reduces symptoms of hyperandrogenism like hirsutism and acne.
